Autonomic dysfunction in primary Sjogren’s syndrome: a prospective cohort analysis of 154 Korean patients
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: To determine the prevalence of autonomic dysfunction among Korean patients with primary Sjogren’s syndrome (pSS) and its associations with the clinical features of pSS. Methods: We analyzed 154 participants from the Korean Initiative of primary Sjogren’s Syndrome (KISS) as a prospective pSS cohort and 154 age- and sexmatched healthy controls. A standardized 5-minute, supine, resting heart rate variability (HRV) test was performed, and autonomic dysfunction was defined as standard deviation of normal-to-normal RR intervals (SDNN) < 30 ms in patients < 50 years old and SDNN < 20 ms in patients ≥ 50 years old. The associations between autonomic dysfunction and various clinical features of pSS were analyzed. Results: The overall autonomic activity in patients with pSS was significantly lower than that in controls. Autonomic dysfunction with the HRV test was observed in 35.7% of the KISS participants and was associated with a higher European League Against Rheumatism Sjogren’s Syndrome Patient Reported Index fatigue score (p = 0.024). Raynaud’s phenomenon was a more frequent clinical presentation in pSS patients with autonomic dysfunction than in those without autonomic dysfunction (29.4% and 14.4%, respectively; p = 0.048). Decreased parasympathetic activity was observed in 41.6% of pSS patients. No differences were found in the oral and ocular signs of pSS according to the decreased parasympathetic activity. Conclusions: In Korean patients with pSS, decreased and imbalanced autonomic activity is prevalent and is associated with fatigue. However, an association between autonomic dysfunction and glandular manifestations was not detected.
Abstract
Background/Aims: To determine the prevalence of autonomic dysfunction among Korean patients with primary Sjogren’s syndrome (pSS) and its associations with the clinical features of pSS. Methods: We analyzed 154 participants from the Korean Initiative of primary Sjogren’s Syndrome (KISS) as a prospective pSS cohort and 154 age- and sexmatched healthy controls. A standardized 5-minute, supine, resting heart rate variability (HRV) test was performed, and autonomic dysfunction was defined as standard deviation of normal-to-normal RR intervals (SDNN) < 30 ms in patients < 50 years old and SDNN < 20 ms in patients ≥ 50 years old. The associations between autonomic dysfunction and various clinical features of pSS were analyzed. Results: The overall autonomic activity in patients with pSS was significantly lower than that in controls. Autonomic dysfunction with the HRV test was observed in 35.7% of the KISS participants and was associated with a higher European League Against Rheumatism Sjogren’s Syndrome Patient Reported Index fatigue score (p = 0.024). Raynaud’s phenomenon was a more frequent clinical presentation in pSS patients with autonomic dysfunction than in those without autonomic dysfunction (29.4% and 14.4%, respectively; p = 0.048). Decreased parasympathetic activity was observed in 41.6% of pSS patients. No differences were found in the oral and ocular signs of pSS according to the decreased parasympathetic activity. Conclusions: In Korean patients with pSS, decreased and imbalanced autonomic activity is prevalent and is associated with fatigue. However, an association between autonomic dysfunction and glandular manifestations was not detected.
참고문헌 (38)
- Fox RI., "Sjogren’s syndrome", Lancet, 366, pp.321~331 (2005)
- Voulgarelis M, "Mortality in Sjogren’s syndrome", Clin Exp Rheumatol, 26(5Suppl 51), pp.S66~S71 (2008)
- Hernandez-Molina G, "Early and late extraglandular manifestations in primary Sjogren’s syndrome", Clin Exp Rheumatol, 30, pp.455~ (2012)
- Barendregt PJ, "Involvement of the peripheral nervous system in primary Sjogren’s syndrome", Ann Rheum Dis, 60, pp.876~881 (2001)
- Andonopoulos AP, "The spectrum of neurological involvement in Sjogren’s syndrome", Br J Rheumatol, 29, pp.21~23 (1990)
- Mandl T, "Autonomic and orthostatic dysfunction in primary Sjogren’s syndrome", J Rheumatol, 34, pp.1869~1874 (2007)
- Ng WF, "Primary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure", QJM, 105, pp.1191~1199 (2012)
- Mandl T, "Autonomic nervous dysfunction development in patients with primary Sjogren’s syndrome: a follow-up study", Rheumatology (Oxford), 49, pp.1101~1106 (2010)
- Humphreys-Beher MG, "An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression", Scand J Immunol, 49, pp.7~10 (1999)
- Newton JL, "Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren’s syndrome", Ann Rheum Dis, 71, pp.1973~1979 (2012)
- Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology., "Heart rate variability: standards of measurement, physiological interpretation and clinical use", Circulation, 93, pp.1043~1065 (1996)
- Vitali C, "Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group", Ann Rheum Dis, 61, pp.554~558 (2002)
- Shiboski SC, "American College of Rheumatology classification criteria for Sjogren’s syndrome: a data-driven, expert consensus approach in the Sjogren’s International Collaborative Clinical Alliance cohort", Arthritis Care Res (Hoboken), 64, pp.475~487 (2012)
- Martinez-Martinez LA, "Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies", J Clin Rheumatol, 20, pp.146~150 (2014)
- Bonnemeier H, "Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability", J Cardiovasc Electrophysiol, 14, pp.791~799 (2003)
- Park SB, "Standardized tests of heart rate variability for autonomic function tests in healthy Koreans", Int J Neurosci, 117, pp.1707~1717 (2007)
- Voss A, "Shortterm heart rate variability: age dependence in healthy subjects", Physiol Meas, 33, pp.1289~1311 (2012)
- Seror R, "EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome", Ann Rheum Dis, 69, pp.1103~1109 (2010)
- Seror R, "EULAR Sjogren’s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren’s syndrome", Ann Rheum Dis, 70, pp.968~972 (2011)
- Thomson WM, "The xerostomia inventory: a multi-item approach to measuring dry mouth", Community Dent Health, 16, pp.12~17 (1999)
- Schiffman RM, "Reliability and validity of the ocular surface disease index", Arch Ophthalmol, 118, pp.615~621 (2000)
- Kovacs L, "Cardiovascular autonomic dysfunction in primary Sjogren’s syndrome", Rheumatology (Oxford), 43, pp.95~99 (2004)
- Niemela RK, "Comprehensive study of autonomic function in a population with primary Sjogren’s syndrome: no evidence of autonomic involvement", J Rheumatol, 30, pp.74~79 (2003)
- Kleiger RE, "Stability over time of variables measuring heart rate variability in normal subjects", Am J Cardiol, 68, pp.626~630 (1991)
- Wulsin LR, "Autonomic imbalance as a predictor of metabolic risks, cardiovascular disease, diabetes, and mortality", J Clin Endocrinol Metab, 100, pp.2443~2448 (2015)
- Sajadieh A, "C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease", J Intern Med, 260, pp.377~387 (2006)
- Tsuji H, "Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study", Circulation, 94, pp.2850~2855 (1996)
- Gravani F, "Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations", Arthritis Res Ther, 17, pp.99~ (2015)
- Bartoloni E, "Cardiovascular disease risk burden in primary Sjogren’s syndrome: results of a population-based multicentre cohort study", J Intern Med, 278, pp.185~192 (2015)
- Konttinen YT, "Topology of innervation of labial salivary glands by protein gene product 9.5 and synaptophysin immunoreactive nerves in patients with Sjogren’s syndrome", J Rheumatol, 19, pp.30~37 (1992)
- Bacman S, "Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome", Invest Ophthalmol Vis Sci, 42, pp.321~327 (2001)
- Bacman S, "Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren’s syndrome", Clin Exp Immunol, 104, pp.454~459 (1996)
- Imrich R, "Predominant glandular cholinergic dysautonomia in patients with primary Sjogren’s syndrome", Arthritis Rheumatol, 67, pp.1345~1352 (2015)
- Tumiati B, "Heart rate variability in patients with Sjogren’s syndrome", Clin Rheumatol, 19, pp.477~480 (2000)
- Segal B, "Prevalence, severity, and predictors of fatigue in subjects with primary Sjogren’s syndrome", Arthritis Rheum, 59, pp.1780~1787 (2008)
- Barendregt PJ, "Fatigue in primary Sjogren’s syndrome", Ann Rheum Dis, 57, pp.291~295 (1998)
- Meeus M, "Heart rate variability in patients with fibromyalgia and patients with chronic fatigue syndrome: a systematic review", Semin Arthritis Rheum, 43, pp.279~287 (2013)
- Nunan D, "A quantitative systematic review of normal values for short-term heart rate variability in healthy adults", Pacing Clin Electrophysiol, 33, pp.1407~1417 (2010)